1 |
coefficient of variation
(861 times)
|
Diagnostic Imaging (156 times)
|
ICC (184 times) SD (33 times) CCT (30 times)
|
1979 Transit-time analysis of the forced spirogram in healthy children and adults.
|
2 |
coronavirus
(676 times)
|
Virology (131 times)
|
SARS (207 times) SARS-CoV-2 (75 times) MERS (71 times)
|
2001 Comparative examination of cats with feline leukemia virus-associated enteritis and other relevant forms of feline enteritis.
|
3 |
SARS-coronavirus
(29 times)
|
Virology (6 times)
|
SARS (15 times) MERS (7 times) COVID-19 (2 times)
|
2005 A large-volume nebulizer would not be an infectious source for severe acute respiratory syndrome.
|
4 |
center of ventilation
(21 times)
|
Anesthesiology (7 times)
|
EIT (15 times) PEEP (7 times) GI (5 times)
|
2014 Detection of 'best' positive end-expiratory pressure derived from electrical impedance tomography parameters during a decremental positive end-expiratory pressure trial.
|
5 |
coefficient of variation of cell size
(5 times)
|
Ophthalmology (3 times)
|
ECD (5 times) CCT (2 times) HEX (2 times)
|
2012 In vivo laser scanning confocal microscopy of the cornea in patients with silicone oil tamponade after vitreoretinal surgery.
|
6 |
SARS-CoV-2, a novel coronavirus
(5 times)
|
Virology (1 time)
|
ChEMBL (1 time) COVID-19 (1 time) HAEC (1 time)
|
2020 A Chemographic Audit of anti-Coronavirus Structure-activity Information from Public Databases (ChEMBL).
|
7 |
Coronaviridae
(4 times)
|
Science (1 time)
|
SARS (2 times) ASA (1 time) ER (1 time)
|
2004 The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world.
|
8 |
pan-coronavirus
(4 times)
|
Virology (2 times)
|
VOCs (3 times) 25-HC (1 time) CH25H (1 time)
|
2021 25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.
|
9 |
compensation voltage
(3 times)
|
Chemistry Techniques, Analytical (3 times)
|
DMS (2 times) 3DP-OPP (1 time) CKD (1 time)
|
2014 Understanding gas phase modifier interactions in rapid analysis by differential mobility-tandem mass spectrometry.
|
10 |
SARS-CoV-2
(3 times)
|
Acquired Immunodeficiency Syndrome (1 time)
|
ACE2 (1 time) ART (1 time) nsp3 (1 time)
|
2020 Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
|
11 |
anti-SARS-coronavirus
(2 times)
|
Allergy and Immunology (1 time)
|
Ab (1 time) CI (1 time) HLA (1 time)
|
2011 Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection.
|
12 |
cases of coronavirus
(2 times)
|
Medicine (1 time)
|
2019-nCoV (1 time) MERS (1 time)
|
2017 Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015.
|
13 |
WIV1-coronavirus
(2 times)
|
Science (1 time)
|
SARS (2 times) ACE2 (1 time)
|
2016 SARS-like WIV1-CoV poised for human emergence.
|
14 |
anti-Corona Virus
(1 time)
|
Microbiological Phenomena (1 time)
|
COVID-19 (1 time) Ct (1 time) RT-PCR (1 time)
|
2022 Milder symptoms and shorter course in patients with re-positive COVID-19: A cohort of 180 patients from Northeast China.
|
15 |
beta-coronavirus
(1 time)
|
Global Health (1 time)
|
CI (1 time) MERS (1 time) MERS-CoV (1 time)
|
2022 Meta-analysis of seroprevalence and zoonotic infections of Middle East respiratory syndrome coronavirus (MERS-CoV): A one-health perspective.
|
16 |
beta-coronaviruses
(1 time)
|
Science (1 time)
|
PCNA (1 time) RBDs (1 time) SARS (1 time)
|
2023 Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge.
|
17 |
Center of Volume
(1 time)
|
Medicine (1 time)
|
SCI (1 time)
|
2013 Quantitative evaluation of 3D mouse behaviors and motor function in the open-field after spinal cord injury using markerless motion tracking.
|
18 |
characteristics of enteric coronavirus
(1 time)
|
Communicable Diseases (1 time)
|
RT-PCR (1 time)
|
2018 Molecular epidemiology of coronavirus in faeces of Brazilian calves and Peruvian camelid herds.
|
19 |
cleavage of the coronavirus
(1 time)
|
|
ISG15 (1 time) PLpro (1 time) SARS-CoV-2 (1 time)
|
2020 Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
|
20 |
coefficient of variation corneal endothelial
(1 time)
|
Eye Diseases (1 time)
|
CCT (1 time) LDH (1 time)
|
2020 Changes of lactate dehydrogenase in corneal edema after cataract surgery treated with trans-corneal oxygenation therapy.
|
21 |
coefficient of variation of the force
(1 time)
|
Brain (1 time)
|
DOMS (1 time) MVC (1 time) RFD (1 time)
|
2011 Eccentric exercise and delayed onset muscle soreness of the quadriceps induce adjustments in agonist-antagonist activity, which are dependent on the motor task.
|
22 |
coefficients of force variation
(1 time)
|
General Surgery (1 time)
|
---
|
2018 Face and Construct Validity of a Novel Virtual Reality-Based Bimanual Laparoscopic Force-Skills Trainer With Haptics Feedback.
|
23 |
conserved between severe acute respiratory syndrome(SARS)coronavirus
(1 time)
|
Genetics, Medical (1 time)
|
3CLpro (1 time) RdRp (1 time) SARS (1 time)
|
2020 Zinc and SARS‑CoV‑2: A molecular modelingstudy of Zn interactions with RNA‑dependentRNA‑polymerase and 3C‑like proteinase enzymes.
|
24 |
construction of coronavirus
(1 time)
|
Molecular Biology (1 time)
|
BACs (1 time)
|
2008 Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes.
|
25 |
contagious viruses in the Coronaviridae
(1 time)
|
Clinical Laboratory Techniques (1 time)
|
PBMC (1 time)
|
2022 Upregulation of hsa_circ_0004812 promotes COVID-19 cytokine storm via hsa-miR-1287-5p/IL6R, RIG-I axis.
|
26 |
corneal volume
(1 time)
|
Ophthalmology (1 time)
|
ACD (1 time) CaV (1 time) CCT (1 time)
|
2017 Evaluation of anterior segment parameters in patients with Turner syndrome using Scheimpflug imaging.
|
27 |
Coronaviridae members
(1 time)
|
Environmental Health (1 time)
|
NGS (1 time)
|
2021 Exploring the diversity of coronavirus in sewage during COVID-19 pandemic: Don't miss the forest for the trees.
|
28 |
Coronavirus infections
(1 time)
|
Pediatrics (1 time)
|
---
|
2021 Multiple-organ failure as a result of non-COVID-19 coronavirus infection.
|
29 |
correlation of variation
(1 time)
|
Optometry (1 time)
|
AL (1 time) CCT (1 time) ICC (1 time)
|
2022 Repeatability and correlation of corneal biomechanical measurements obtained by Corvis ST in orthokeratology patients.
|
30 |
cost of verification
(1 time)
|
Psychology (1 time)
|
CoE (1 time)
|
2009 Age-related differences in reliance behavior attributable to costs within a human-decision aid system.
|
31 |
covariance of variation
(1 time)
|
Neurology (1 time)
|
QoL (1 time) RBANS (1 time) WNV (1 time)
|
2018 Does intra-individual neurocognitive variability relate to neuroinvasive disease and quality of life in West Nile Virus?
|
32 |
covariances
(1 time)
|
Neurology (1 time)
|
CANTAB (1 time) MDD (1 time) rCBF (1 time)
|
2022 Effect of Low-Dose Statins in Addition to Standard Therapy on Brain Perfusion and Neurocognitive Performance in Patients with Major Depressive Disorder.
|
33 |
COVID
(1 time)
|
|
AI (1 time) ML (1 time)
|
2021 AI in Fighting Covid-19: Pandemic Management.
|
34 |
COVID-19 caused by SARS-coronavirus
(1 time)
|
Biology (1 time)
|
CMNMF (1 time) VDAs (1 time)
|
2021 A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
|
35 |
COVID-19 is the coronavirus
(1 time)
|
Virology (1 time)
|
ACE2 (1 time) RBD (1 time)
|
2020 On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.
|
36 |
COVID-19 novel coronavirus
(1 time)
|
Virology (1 time)
|
ACE2 (1 time) MERS (1 time) NTD (1 time)
|
2020 The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.
|
37 |
COVID-19-related coronavirus
(1 time)
|
Anesthesia (1 time)
|
PHEIC (1 time) WHO (1 time)
|
2021 Unusual routes for transmission of coronavirus disease (COVID-19): Recommendations to interrupt the vicious cycle of infection.
|
38 |
coxsackievirus
(1 time)
|
Microbiology (1 time)
|
FCV (1 time) MNV (1 time) PoV (1 time)
|
2018 Eligibility of Feline Calicivirus for a Surrogate of Human Norovirus in Comparison with Murine Norovirus, Poliovirus and Coxsackievirus.
|
39 |
cross-coronavirus
(1 time)
|
Virology (1 time)
|
KD (1 time) MIS-C (1 time)
|
2022 Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease.
|
40 |
cut off value
(1 time)
|
Medicine (1 time)
|
IgA (1 time) NPC (1 time)
|
2017 Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.
|
41 |
gene(s)-coronavirus
(1 time)
|
Natural Science Disciplines (1 time)
|
COVID-19 (1 time) FDA (1 time) SARS-CoV-2 (1 time)
|
2022 Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference.
|
42 |
SARS-CoV-2 strains from the coronavirus
(1 time)
|
Medicine (1 time)
|
SARS-CoV-2-3CLpro (1 time)
|
2021 Phytochemicals against SARS-CoV as potential drug leads.
|
43 |
SARS-CoV-2, the recently emerged coronavirus
(1 time)
|
Genetics, Medical (1 time)
|
---
|
2021 Decoding Covid-19 with the SARS-CoV-2 Genome.
|